Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3289-3295, June 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okunieff, P.
Right arrow Articles by Beshah, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okunieff, P.
Right arrow Articles by Beshah, K.

Angiogenesis Determines Blood Flow, Metabolism, Growth Rate, and ATPase Kinetics of Tumors Growing in an Irradiated Bed: 31P and 2H Nuclear Magnetic Resonance Studies1

Paul Okunieff2, Stephan Dols3, Junhee Lee3, Samuel Singer4, Peter Vaupel5, Leo J. Neuringer4 and Kebede Beshah4

Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114

Experimental tumors growing in irradiated tissue have been used to study the biological differences characteristic of locally recurrent tumors. Since the hypoxic cell fraction of tumors growing in irradiated tissue is increased and growth rate is slowed, these tumors are assumed to be metabolically deprived with hypoperfusion. In this study, we directly measured the effect of tumor bed irradiation on blood flow, growth rate, rate of nucleoside triphosphate (NTP) turnover, and metabolic state using 31P and 2H nuclear magnetic resonance, and an intradermal assay for angiogenesis. (NTP turnover refers to ATP-synthetase mediated NTP turnover that is visible to 31P nuclear magnetic resonance using the technique of saturation transfer.) A decrease in the number of small blood vessels perfusing tumors in a preirradiated bed was found. Most of the decrease was due to a loss of vessels with diameters less than 0.04 mm. When tumors growing in preirradiated tissue reached {approx}100 mm3 in volume, a high frequency of gross and microscopic necrosis and hemorrhage was already observed in most tumors. Consistent with these observations, the phosphocreatine/inorganic phosphate and nucleoside triphosphate/inorganic phosphate ratios were significantly lower in the tumors growing in a preirradiated bed compared with tumors in a nonirradiated bed. The blood flow rate was similar to control for tumors less than 100 mm3 (45.8 versus 40.5 ml/100 g/min, P = not significant), but was significantly lower than control for tumors greater than 100 mm3 (40.4 versus 12.2 ml/100 g/min, P < 0.01). The NTP turnover rates correlated (P < 0.005, r = 0.66) with the volume doubling rate (1/tumor volume doubling time), but for tumors {approx}100 mm3 in size neither the volume doubling rate nor the NTP turnover rate of tumors growing in an irradiated bed was statistically lower than control [NTP turnover: 14 ± 3%/s versus 9 ± 2%/s; volume doubling rate: 0.47 ± 0.07/day versus 0.33 ± 0.04/day (mean ± SE)]. A large intertumor variability of all metabolic parameters was observed.

1 This work was supported in part by NIH Grants CA48096, CA13311, and RR00995, as well as an American Cancer Society Career Development Award and Research Grant PDT-313, and the Deutscher Akademischer Austauschdienst.

2 To whom requests for reprints should be addressed, at Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114.

3 Present address: Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114.

4 Present address: Francis Bitter National Magnetic Laboratory, Massachusetts Institute of Technology, 170 Albany Street, Cambridge, MA 02139.

5 Present address: Institute of Physiology and Pathophysiology, Pathophysiology Division, University of Mainz, D-6500 Mainz, Federal Republic of Germany.

Received 8/28/90. Accepted 4/ 1/91.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. V. Kozin, F. Winkler, I. Garkavtsev, D. J. Hicklin, R. K. Jain, and Y. Boucher
Human Tumor Xenografts Recurring after Radiotherapy Are More Sensitive to Anti-Vascular Endothelial Growth Factor Receptor-2 Treatment than Treatment-Naive Tumors
Cancer Res., June 1, 2007; 67(11): 5076 - 5082.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. K. Rofstad, B. Mathiesen, K. Henriksen, K. Kindem, and K. Galappathi
The Tumor Bed Effect: Increased Metastatic Dissemination from Hypoxia-Induced Up-regulation of Metastasis-Promoting Gene Products
Cancer Res., March 15, 2005; 65(6): 2387 - 2396.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.